CODA Genomics Becomes Verdezyne

Laguna Hills-based CODA Genomics, which is developing technology for engineering proteins, metabolic pathways and microorganisms for the life sciences, chemical, and biofuels market, said Tuesday that it is renaming itself Verdezyne, Inc. The firm, which is venture backed by OVP Venture PArtners, Monitor Ventures, the Tech Coast Angels, and the Life Science Angels, said the move better conveys the company's focus on manufacturing platform chemicals and biofuels. The firm's technology is being applied to the commercial fermentation process, which is used for biofuels and chemical manufacturing.